tiprankstipranks
Indivior Director Acquires Significant Shareholding
Company Announcements

Indivior Director Acquires Significant Shareholding

Story Highlights
  • Indivior operates in the pharmaceutical industry, focusing on addiction treatment.
  • Director Robert Schriesheim acquired 21,400 shares, indicating confidence in the company.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Don't Miss Our Christmas Offers:

Indivior ( (GB:INDV) ) has provided an announcement.

Indivior PLC announced that Robert Schriesheim, a Non-Executive Director, acquired 21,400 Ordinary Shares at $11.73 each on December 20, 2024. This transaction reflects a potential vote of confidence in the company’s operations and market positioning, potentially signaling positive implications for stakeholders.

More about Indivior

Indivior PLC operates in the pharmaceutical industry, focusing primarily on the development and distribution of medications for addiction treatment and related health issues.

YTD Price Performance: -22.83%

Average Trading Volume: 462,023

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £1.15B

For detailed information about INDV stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskIndivior PLC Restructures Board to Enhance Shareholder Value
TipRanks UK Auto-Generated NewsdeskIndivior Advances Share Repurchase Initiative
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App